CAM
AMPH icon

Capstone Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Capstone Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,420
Closed -$192K – 1606
2016
Q4 		$192K Buy
+10,420
New +$203K 0.01% 1559

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capstone Asset Management's AMPH Position: Q1 2017 in Review

Capstone Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2017, closing a stake of 10,420 shares — an estimated $192K sold.

Capstone Asset Management first reported a position in AMPH in Q4 2016 and held it in 1 quarter. The position peaked at $192K in Q4 2016. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2017.

  • Capstone Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Capstone Asset Management sold 10,420 Amphastar Pharmaceuticals shares in Q1 2017, an estimated $192K.
  • Capstone Asset Management first reported a position in Amphastar Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Capstone Asset Management's Amphastar Pharmaceuticals position peaked at $192K in Q4 2016.
  • 116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2017.

Based on Capstone Asset Management's 13F filing for Q1 2017, filed 12 Apr 2017.